LL-37 5mg Research Peptide Canada

Antimicrobial Peptide for Innate Immunity & Cellular Signalling Research (Canada)

LL‑37 is a synthetic research peptide derived from the human cathelicidin antimicrobial peptide family, widely studied in laboratory settings for its role in innate immune responses, host‑defence mechanisms, and cell‑signalling pathways. It is commonly referenced in experimental models involving peptide–membrane interactions, inflammatory signalling pathways, and microbial response systems.

Supplied by BlueNex Labs, LL‑37 is provided as a lyophilized research peptide with lot-documented analytical consistency and audit‑safe Research‑Use‑Only (RUO) labelling, supporting advanced experimental workflows across Canadian research laboratories.

LL‑37 is frequently utilized in controlled laboratory environments to explore peptide‑mediated signalling and host‑defence mechanisms.

In research settings, LL‑37 is commonly referenced in studies examining:

• Innate immune response signalling pathways
• Antimicrobial peptide interactions with membranes
• Cellular signalling modulation and pathway activation
• Inflammatory response models and signalling cascades
• Host–pathogen interaction frameworks

Its broad signalling profile supports multi-system analysis in controlled experimental designs.

LL‑37 is a synthetic analogue of a naturally occurring human antimicrobial peptide, designed for laboratory studies involving:

• Innate immune system signalling
• Peptide–cell membrane interactions
• Cellular communication and signalling pathways

Its structure enables researchers to investigate peptide function within complex biological systems under controlled conditions.

In research contexts, LL‑37 supports studies involving:

• Signal transduction and pathway activation
• Peptide‑mediated cellular responses
• Interaction between peptides and microbial structures
• Regulatory signalling within immune‑associated pathways

🔵 Innate Immune Signalling

• Referenced in studies involving host‑defence peptide activity
• Used in models examining immune‑associated signalling pathways
• Supports investigation of intracellular signalling cascades

🟠 Peptide–Membrane Interaction Studies

• Applied in research examining peptide binding to lipid membranes
• Supports structural and functional interaction modelling
• Used in membrane‑permeability and signalling studies

🟣 Inflammatory Signalling Models

• Examined in studies involving pathway‑level signalling responses
• Supports analysis of signalling modulation mechanisms
• Used in comparative inflammatory pathway models

🔗 Host–Pathogen Interaction Research

• Enables investigation of peptide responses in microbial systems
• Supports modelling of interaction dynamics
• Used in studies of peptide‑mediated signalling behaviour

Type: Synthetic antimicrobial peptide

Form: Lyophilized powder

Identity Verification: Mass Spectrometry (MS)

Purity Analysis: HPLC / UPLC

Structural & Biochemical Notes

• Derived from human cathelicidin peptide sequence
• Demonstrates a consistent analytical readout in laboratory workflows
• Suitable for signalling and membrane interaction studies
• Sensitive to degradation depending on storage and handling conditions

LL‑37 is widely referenced in laboratory research involving:

• Innate immune signalling pathway analysis
• Peptide‑membrane interaction studies
• Host–pathogen interaction modelling
• Inflammatory signalling pathway research
• Structure–function analysis of antimicrobial peptides

Its versatility supports a wide range of controlled experimental applications in regulated research environments.

• Store lyophilized LL-37 at −20 °C, protected from light and moisture
• Avoid repeated freeze–thaw cycles; aliquot according to your laboratory SOP

Batch Certificates of Analysis are listed in the certificates library when published. Match vial size and lot notes before assigning a lot to an assay.

Research use only. Not for human or veterinary use. No medical, cosmetic, or performance claims are made or implied.